Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Farmer A et al. - Among patients with type 2 diabetes, those treated with insulin used SMBG at a greater frequency than those not treated with insulin. Increased frequency of testing was associated with increased frequency of self-reported episodes of low blood glucose, even among patients not taking insulin or sulfonylureas. This raises the possibility that episodes of hypoglycaemia may not be accurately identified, leading to unnecessary fear, or conversely that treatment is not being adjusted to avoid such morbidity.


Previous Article Next Article

Today in Diagnostics...keeping you current

Diabetes Experts Recommend A1c Testing for Diabetes Diagnosis
American Family Physician, 06/25/09

Continuous Glucose Sensing: Future Technology Developments
Diabetes Technology & Therapeutics, 06/05/09

Continuous Glucose Monitoring Health Outcomes
Diabetes Technology & Therapeutics, 06/04/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address